Subscribe To
CSII / Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
CSII News
By Zacks Investment Research
April 5, 2023
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calc more_horizontal
By Zacks Investment Research
March 20, 2023
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes
Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII). more_horizontal
By Seeking Alpha
February 15, 2023
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems i more_horizontal
By Zacks Investment Research
February 10, 2023
Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss
With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance. more_horizontal
By The Motley Fool
February 9, 2023
Why Cardiovascular Systems Stock Is Soaring Today
The medtech company has agreed to a buyout offer from Abbott Laboratories. more_horizontal
By InvestorPlace
February 9, 2023
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
Cardiovascular Systems (NASDAQ: CSII ) stock is rising higher on Thursday following news that Abbott (NYSE: ABT ) intends to acquire the company. That more_horizontal
By Market Watch
February 9, 2023
Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million
Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 mil more_horizontal
By Zacks Investment Research
February 8, 2023
Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -33.33% and 2.70%, respectively, for the quarter ended December 2022. Do the more_horizontal